Skip to main content
. 2008 Jan 29;374(1):151–163. doi: 10.1016/j.virol.2007.12.032

Table 2.

SARS-CoV Toronto 2 vRNA detected in ferret swabs and tissues

SARS-CoV Infected Group 2 (d.p.i.) NS PS RS T (u) T (l) GI (C) GI (D) NT LUNG LIVER
2 4/4 4/4 0/4 0/4 0/4 0/4 0/4 3/4 2/4 0/4
3 4/4 4/4 0/4 0/4 0/4 0/4 0/4 3/4 1/4 0/4
5 4/4 4/4 1/4 0/4 0/4 0/4 0/4 4/4 4/4 0/4
7 3/4 3/4 0/4 0/4 0/4 0/4 0/4 4/4 4/4 0/4
14 0/4 0/4 0/4 0/4 0/4 0/4 0/4 1/4 0/4 0/4
28 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4



SARS-CoV Challenged Group 4 (d.p.i.)

31 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
32 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
34 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
36 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
43 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
57 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3

Table shows the number of positive per total sample number analyzed in indicated swab and tissue homogenates. Legend: NS-Nasal Swab; PS-Pharyngeal Swab; RS-Rectal Swab; T(u)-Trachea (upper); T(l) Trachea (lower); GI (C)-GI colon; GI (D)-GI duodenum; NT-Nasal Turbinates.